Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034661714> ?p ?o ?g. }
- W2034661714 endingPage "1693" @default.
- W2034661714 startingPage "1673" @default.
- W2034661714 abstract "Hepatitis C virus is a blood-borne infection and the leading cause of chronic liver disease (including cirrhosis and cancer) and liver transplantation. Since the identification of HCV in 1989, there has been an extensive effort to identify and improve treatment options. An important milestone was reached in 2011 with the approval of the first-generation HCV NS3/4A protease inhibitors. However, new therapies are needed to improve cure rates, shorten treatment duration, and improve tolerability. Here we summarize the extensive medicinal chemistry effort to develop novel P2 cyclopentane macrocyclic inhibitors guided by HCV NS3 protease assays, the cellular replicon system, structure-based design, and a panel of DMPK assays. The selection of compound 29 (simeprevir, TMC435) as clinical candidate was based on its excellent biological, PK, and safety pharmacology profile. Compound 29 has recently been approved for treatment of chronic HCV infection in combination with pegylated interferon-α and ribavirin in Japan, Canada, and USA." @default.
- W2034661714 created "2016-06-24" @default.
- W2034661714 creator A5002491926 @default.
- W2034661714 creator A5003318820 @default.
- W2034661714 creator A5008135920 @default.
- W2034661714 creator A5009503287 @default.
- W2034661714 creator A5027057125 @default.
- W2034661714 creator A5031660163 @default.
- W2034661714 creator A5039740102 @default.
- W2034661714 creator A5041362155 @default.
- W2034661714 creator A5043951728 @default.
- W2034661714 creator A5052896698 @default.
- W2034661714 creator A5060845872 @default.
- W2034661714 creator A5069775097 @default.
- W2034661714 creator A5082431815 @default.
- W2034661714 creator A5088780090 @default.
- W2034661714 date "2014-02-14" @default.
- W2034661714 modified "2023-10-17" @default.
- W2034661714 title "Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor" @default.
- W2034661714 cites W1482367278 @default.
- W2034661714 cites W1497131577 @default.
- W2034661714 cites W1950519143 @default.
- W2034661714 cites W1966138923 @default.
- W2034661714 cites W1972875606 @default.
- W2034661714 cites W1977935857 @default.
- W2034661714 cites W1979174109 @default.
- W2034661714 cites W1987935503 @default.
- W2034661714 cites W1990127122 @default.
- W2034661714 cites W1993274621 @default.
- W2034661714 cites W1999767209 @default.
- W2034661714 cites W2001129358 @default.
- W2034661714 cites W2001138984 @default.
- W2034661714 cites W2002608073 @default.
- W2034661714 cites W2006309458 @default.
- W2034661714 cites W2007176661 @default.
- W2034661714 cites W2007198481 @default.
- W2034661714 cites W2012503063 @default.
- W2034661714 cites W2013982103 @default.
- W2034661714 cites W2017083021 @default.
- W2034661714 cites W2020914906 @default.
- W2034661714 cites W2022057836 @default.
- W2034661714 cites W2022086682 @default.
- W2034661714 cites W2023563124 @default.
- W2034661714 cites W2023926449 @default.
- W2034661714 cites W2029414153 @default.
- W2034661714 cites W2033246179 @default.
- W2034661714 cites W2035035323 @default.
- W2034661714 cites W2041273833 @default.
- W2034661714 cites W2041882184 @default.
- W2034661714 cites W2046658390 @default.
- W2034661714 cites W2052000792 @default.
- W2034661714 cites W2052924269 @default.
- W2034661714 cites W2053068378 @default.
- W2034661714 cites W2060399390 @default.
- W2034661714 cites W2064745369 @default.
- W2034661714 cites W2068361598 @default.
- W2034661714 cites W2078125666 @default.
- W2034661714 cites W2080696565 @default.
- W2034661714 cites W2085587542 @default.
- W2034661714 cites W2091937293 @default.
- W2034661714 cites W2093481346 @default.
- W2034661714 cites W2096411838 @default.
- W2034661714 cites W2099272027 @default.
- W2034661714 cites W2100797437 @default.
- W2034661714 cites W2104713245 @default.
- W2034661714 cites W2110187158 @default.
- W2034661714 cites W2117718017 @default.
- W2034661714 cites W2121119506 @default.
- W2034661714 cites W2125963799 @default.
- W2034661714 cites W2129743974 @default.
- W2034661714 cites W2138401012 @default.
- W2034661714 cites W2140369033 @default.
- W2034661714 cites W2140688181 @default.
- W2034661714 cites W2141214317 @default.
- W2034661714 cites W2141361007 @default.
- W2034661714 cites W2142684817 @default.
- W2034661714 cites W2143278579 @default.
- W2034661714 cites W2143559032 @default.
- W2034661714 cites W2145130602 @default.
- W2034661714 cites W2158177781 @default.
- W2034661714 cites W2159414436 @default.
- W2034661714 cites W2160748326 @default.
- W2034661714 cites W2162287933 @default.
- W2034661714 cites W2163503894 @default.
- W2034661714 cites W2166962970 @default.
- W2034661714 cites W2320932054 @default.
- W2034661714 cites W2952163460 @default.
- W2034661714 cites W4239019537 @default.
- W2034661714 cites W46543907 @default.
- W2034661714 doi "https://doi.org/10.1021/jm401507s" @default.
- W2034661714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24446688" @default.
- W2034661714 hasPublicationYear "2014" @default.
- W2034661714 type Work @default.
- W2034661714 sameAs 2034661714 @default.
- W2034661714 citedByCount "175" @default.
- W2034661714 countsByYear W20346617142014 @default.
- W2034661714 countsByYear W20346617142015 @default.
- W2034661714 countsByYear W20346617142016 @default.